Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 5 studies | 20% ± 2% | |
dendritic cell | 3 studies | 32% ± 3% |
Insufficient scRNA-seq data for expression of MYCL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 98% | 1973.36 | 323 / 328 | 71% | 12.84 | 127 / 178 |
prostate | 80% | 561.87 | 197 / 245 | 88% | 10.39 | 443 / 502 |
liver | 81% | 681.66 | 183 / 226 | 76% | 9.94 | 309 / 406 |
bladder | 62% | 1873.52 | 13 / 21 | 95% | 64.10 | 478 / 504 |
stomach | 70% | 451.29 | 253 / 359 | 74% | 7.68 | 213 / 286 |
intestine | 47% | 336.29 | 455 / 966 | 88% | 10.89 | 466 / 527 |
thymus | 72% | 316.62 | 470 / 653 | 57% | 6.52 | 345 / 605 |
lung | 42% | 143.79 | 241 / 578 | 85% | 17.37 | 979 / 1155 |
esophagus | 39% | 957.72 | 560 / 1445 | 83% | 94.62 | 152 / 183 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.19 | 1 / 1 |
brain | 15% | 42.94 | 397 / 2642 | 84% | 10.84 | 592 / 705 |
ovary | 0% | 0 | 0 / 180 | 97% | 33.69 | 416 / 430 |
skin | 72% | 3766.38 | 1301 / 1809 | 23% | 1.28 | 107 / 472 |
breast | 17% | 56.39 | 80 / 459 | 69% | 6.84 | 768 / 1118 |
uterus | 4% | 31.59 | 6 / 170 | 81% | 20.34 | 372 / 459 |
spleen | 75% | 310.64 | 180 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 5.23 | 17 / 29 |
peripheral blood | 37% | 158.56 | 345 / 929 | 0% | 0 | 0 / 0 |
kidney | 12% | 32.43 | 11 / 89 | 21% | 1.27 | 192 / 901 |
eye | 0% | 0 | 0 / 0 | 21% | 1.19 | 17 / 80 |
muscle | 4% | 15.87 | 33 / 803 | 0% | 0 | 0 / 0 |
adipose | 1% | 10.31 | 13 / 1204 | 0% | 0 | 0 / 0 |
heart | 1% | 2.38 | 7 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 3.19 | 10 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.01 | 1 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045607 | Biological process | regulation of inner ear auditory receptor cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | MYCL |
Protein name | Protein L-Myc (Class E basic helix-loop-helix protein 38) (bHLHe38) (Protein L-Myc-1) (V-myc myelocytomatosis viral oncogene homolog) MYCL proto-oncogene, bHLH transcription factor |
Synonyms | LMYC BHLHE38 MYCL1 |
Description | |
Accessions | ENST00000397332.3 [P12524-3] ENST00000372815.1 [P12524-2] P12524 E9PQS5 ENST00000450953.3 ENST00000372816.3 [P12524-1] |